The randomised control trial notes that frequency of defecation and watery stools reduced following supplementation with B. infantis M-63 in infants up until three months of age, compared to the placebo group.
You May Also Like

Study: Fucosylated HMOs may improve infant cognitive development, whilst sialyated types may not
INCMarch 27, 2023

Global conference on infant nutrition in Wellington
INCOctober 17, 2022

US formula shortage: FDA refutes claims of postponing all applications under discretion policy
INCAugust 30, 2022